홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
PBYI
#3121
PUMA BIOTECHNOLOGY INC
7.5
8
USD
+0.13%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.13%
월간 변동
+26.33%
6달 변화
+41.95%
년간 변동율
+158.70%
이전 종가
7.5
7
Open
7.6
0
Bid
Ask
Low
7.5
8
High
7.6
1
양
18
마켓
주식
헬스케어
PBYI
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
40.26 M
41.33 M
46.64 M
48.21 M
49.61 M
50.88 M
—
Valuation ratios
Enterprise value
434.43 M
179.16 M
230.71 M
211.05 M
110.85 M
279.1 M
734.12 M
Price to earnings ratio
—
—
—
10.06
4.92
9.75
24.09
Price to sales ratio
—
—
0.81
0.91
0.65
1.32
3.91
Price to cash flow ratio
—
—
-11.72
7.97
3.85
7.21
21.86
Price to book ratio
—
—
8.59
4.03
1.63
2.31
3.9
EBITDA 비율에 대한 기업 가치
-15.46
31.37
3.68
4.31
2.83
7.56
17.36
Profitability ratios
Return on assets %
-0.25
-0.13
0
0.09
0.14
0.14
0.15
Return on equity %
10.08
11.91
0
0.4
0.33
0.24
0.27
Return on invested capital %
-116.13
4.51
0.4
104.46
128.94
130.27
131.57
Gross margin %
100
74.84
75.84
73.4
72.06
74.53
300.6
Operating margin %
-13.51
0.51
10.4
13.85
13.44
16.33
61.56
EBITDA margin %
-9.42
0.79
13.86
13.15
12.6
15.81
68.6
Net margin %
-26.65
-11.51
0
9.16
13.14
13.62
51.67
Liquidity ratios
Quick ratio
1.25
1.21
1.67
1.5
1.45
1.93
6.6
Current ratio
1.28
1.28
1.73
1.57
1.54
2
6.99
Inventory turnover
—
12.06
9.47
10.8
8.15
8.17
7.06
Asset turnover
0.94
1.08
1.02
1.04
1.04
1.06
1.13
Solvency ratios
Debt to assets ratio
0.44
0.51
0.51
0.34
0.13
0.03
0.23
Debt to equity ratio
-17.92
-47.69
5.29
1.45
0.31
0.05
0.42
Long term debt to total assets ratio
0.34
0.43
0.44
0.28
0.1
0
0.11
Long term debt to total equity ratio
-14.12
-39.69
4.55
1.23
0.24
0
0.21
Per share metrics
Operating cash flow per share
—
—
-0.35
0.57
0.79
0.83
0.83
EBIT per share
—
—
0.53
0.69
0.63
0.74
0.74
EBITDA per share
—
—
0.7
0.65
0.59
0.71
0.86
Total debt per share
—
—
2.54
1.63
0.59
0.12
0.9
Cash per share
—
—
1.04
1.03
1.77
1.81
6.96
Net current asset value per share
—
—
2.99
3.28
3.01
3.21
11.41
Tangible book value per share
—
—
-1.09
-0.16
0.83
1.76
5.29
Working capital per share
—
—
1.26
1.19
1.05
1.61
4.87
Book value per share
—
—
0.48
1.12
1.88
2.57
8.87
Puma Biotechnology Inc
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
뉴스
Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
퓨마 바이오, TD Cowen 컨퍼런스 참가: 전략적 성장과 재정 건전성
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27
Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates
Puma Biotech Q4 실적, 수익 예상치를 넘어
Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates
Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates
Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com